Updated on 16 Sep 2026, 09:55 PM IST
|
| ||||
|
| ||||
| Meeting Date | Purpose |
|---|---|
| 2026-07-23 | Quarterly Results |
| 2026-05-07 | Audited Results & Final Dividend |
| 2026-01-28 | Quarterly Results |
| 2025-10-14 | Qtr Results, Int. Dividend & Bonus issue |
| 2025-07-23 | Quarterly Results |
Thyrocare Technologies is trading at 544.50 as on Wed Sep 16 2026 09:59:56. This is -0.02% lower as compared to its previous closing price of 544.60.
The market capitalization of Thyrocare Technologies is 8624.08 Cr as on Wed Sep 16 2026 09:59:56.
The average broker rating on Thyrocare Technologies is Strong Buy. The breakup of analyst rating is given below -
The 52 wk high for Thyrocare Technologies is 662.00 whereas the 52 wk low is 342.55
Thyrocare Technologies can be analyzed on the following key metrics -
Thyrocare Technologies reported a net profit of 163.04 Cr in 2026.
The Mutual Fund Shareholding was 19.86% at the end of 30 Jun 2026.
Oops! Looks like you have exceeded the limit to bookmark the image. Remove some to bookmark this image.